HTD1265 Disrupts GimC-Dependent Cellular Processes in Saccharomyces cerevisiae
Pathogens · 2026
DOI: 10.3390/pathogens15020185 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2026. Verfasst von Kaori Itto-Nakama und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrated Biosciences, Graduate School of Frontier Sciences, The University of Tokyo, 5-1-5 Kashiwano-ha, Kashiwa 277-8562, Chiba, Jap…. Hauptthemen laut MEDLINE: Saccharomyces cerevisiae, Antifungal Agents, Candida, Saccharomyces cerevisiae Proteins. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI, JSPS Program for Forming Japan's Peak Research Universities (J-PEAKS), JSPS Program for Forming Japan’s Peak Research Universities.
Abstract (Originalsprache)
HTD1265 is a newly identified antifungal compound that displays potent activity against Candida krusei, a clinically challenging non-albicans species. To elucidate its mechanism of action, we applied an integrative phenotypic approach combining high-resolution morphological profiling, pathway inference, and genetic validation in Saccharomyces cerevisiae. Morphological signature extraction revealed a characteristic defect in nuclear positioning upon HTD1265 treatment. Integration of nuclear positioning traits with global morphological similarity highlighted 36 genes enriched for the Gene Ontology term “tubulin complex assembly.” Consistent with this prediction, HTD1265 impaired mitotic spindle elongation without directly inhibiting tubulin polymerization. HTD1265 further induced hallmarks of GimC (prefoldin) deficiency, including aberrant chitin accumulation, actin disorganization, and nuclear mispositioning, and caused hypersensitivity in GimC subunit mutants. These converging observations suggest that HTD1265 exerts antifungal activity by disrupting GimC-dependent cellular processes rather than by directly targeting tubulin. Our findings highlight GimC-dependent cytoskeletal and cell wall regulatory processes as a critical vulnerability for fungal growth and position HTD1265 as a functional tool for dissecting this pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Integrated Biosciences, Graduate School of Frontier Sciences, The University of Tokyo, 5-1-5 Kashiwano-ha, Kashiwa 277-8562, Chiba, Japan.
- RIKEN Center for Sustainable Resource Science, 2-1 Hirosawa, Wako 351-0198, Saitama, Japan.
- Institute of Life and Environmental Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8572, Ibaraki, Japan.
- Institute of Microbial Chemistry (BIKAKEN), 3-14-23 Kamiosaki, Shinagawa-ku, Tokyo 141-0021, Japan.
- Terrence Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON M5S 3E1, Canada.
- Collaborative Research Institute for Innovative Microbiology (CRIIM), The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan.
ORCID-Profile: Shinsuke Ohnuki, Fumiyuki Shirai, Hiroyuki Osada, Yoshikazu Ohya
Förderung
- JSPS KAKENHI
- JSPS Program for Forming Japan's Peak Research Universities (J-PEAKS)
- JSPS Program for Forming Japan’s Peak Research Universities
Zitieren
APA
Itto-Nakama, K., Hosoyamada, N., Ohnuki, S., Shirai, F., Mukaiyama, M., Hirano, H., Osada, H., Boone, C., Usui, T., Yashiroda, Y., & Ohya, Y. (2026). HTD1265 Disrupts GimC-Dependent Cellular Processes in Saccharomyces cerevisiae. Pathogens. https://doi.org/10.3390/pathogens15020185
Vancouver
Itto-Nakama K, Hosoyamada N, Ohnuki S, Shirai F, Mukaiyama M, Hirano H, et al. HTD1265 Disrupts GimC-Dependent Cellular Processes in Saccharomyces cerevisiae. Pathogens. 2026. doi:10.3390/pathogens15020185
BibTeX
@article{IttoNakama2026,
author = {Itto-Nakama, Kaori and Hosoyamada, Naoya and Ohnuki, Shinsuke and Shirai, Fumiyuki and Mukaiyama, Minagi and Hirano, Hiroyuki and Osada, Hiroyuki and Boone, Charles and Usui, Takeo and Yashiroda, Yoko and Ohya, Yoshikazu},
title = {HTD1265 Disrupts GimC-Dependent Cellular Processes in Saccharomyces cerevisiae},
journal = {Pathogens},
year = {2026},
doi = {10.3390/pathogens15020185}
}
EUVIMED